Balyasny Asset Management Portfolio holdings
AUM
$53.4B
1-Year Est. Return
35.11%
This Fund
S&P 500
1 Year Est. Return
+35.11%
AUM
$53.4B
AUM Growth
+$3.81B
(+7.7%)
Holding
2,683
Top Buys
| 1 | +$807M | |
| 2 | +$497M | |
| 3 | +$390M | |
| 4 |
Kenvue
KVUE
|
+$379M |
| 5 |
Broadcom
AVGO
|
+$324M |
Top Sells
| 1 | +$409M | |
| 2 | +$354M | |
| 3 | +$328M | |
| 4 |
Meta Platforms (Facebook)
META
|
+$317M |
| 5 |
Lockheed Martin
LMT
|
+$316M |
Sector Composition
| 1 | Technology | 17.25% |
| 2 | Consumer Discretionary | 14.26% |
| 3 | Healthcare | 12.06% |
| 4 | Industrials | 11.95% |
| 5 | Financials | 11.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
651
DXC Technology
DXC
$2.08B
| $12.1M | 0.02% |
823,161
+812,236
|
|
||
652
Adobe
ADBE
$112B
| $12M | 0.02% |
34,229
+1,632
|
|
||
|
GLXY
653
Galaxy Digital Inc
GLXY
$4.16B
| $12M | 0.02% |
535,661
-293,657
|
|
||
654
Ultragenyx Pharmaceutical
RARE
$2.21B
| $12M | 0.02% |
+520,054
|
|
||
655
NextDecade
NEXT
$1.47B
| $11.9M | 0.02% |
2,267,259
+2,189,095
|
|
||
656
Nektar Therapeutics
NKTR
$2.02B
| $11.9M | 0.02% |
282,021
+99,207
|
|
||
657
Alignment Healthcare
ALHC
$3.7B
| $11.9M | 0.02% |
600,462
-1,030,358
|
|
||
658
Palo Alto Networks
PANW
$135B
| $11.8M | 0.02% |
64,154
+37,006
|
|
||
659
Merit Medical Systems
MMSI
$4.14B
| $11.8M | 0.02% |
133,438
+56,828
|
|
||
|
CNTA
660
Centessa Pharmaceuticals
CNTA
$4.08B
| $11.7M | 0.02% |
468,815
-336,796
|
|
||
661
TPG
TPG
$6.77B
| $11.7M | 0.02% |
183,039
-1,095,126
|
|
||
662
Genmab
GMAB
$17.2B
| $11.7M | 0.02% |
+379,364
|
|
||
663
Estee Lauder
EL
$34.1B
| $11.6M | 0.02% |
+111,225
|
|
||
664
SiriusXM
SIRI
$7.29B
| $11.6M | 0.02% |
580,841
+507,950
|
|
||
665
CubeSmart
CUBE
$9.08B
| $11.6M | 0.02% |
+321,962
|
|
||
666
Atlas Energy Solutions
AESI
$1.54B
| $11.5M | 0.02% |
1,223,333
+1,123,767
|
|
||
667
HNI Corp
HNI
$2.88B
| $11.5M | 0.02% |
273,961
+247,361
|
|
||
668
ServiceNow
NOW
$122B
| $11.5M | 0.02% |
75,036
+34,566
|
|
||
|
PVLA
669
Palvella Therapeutics
PVLA
$1.99B
| $11.4M | 0.02% |
108,880
-57,655
|
|
||
670
Labcorp
LH
$22.1B
| $11.4M | 0.02% |
45,400
-72,854
|
|
||
671
Datadog
DDOG
$43.6B
| $11.4M | 0.02% |
83,646
+12,487
|
|
||
672
News Corp Class A
NWSA
$13.3B
| $11.4M | 0.02% |
435,380
+422,148
|
|
||
673
Range Resources
RRC
$9.57B
| $11.4M | 0.02% |
322,406
-111,852
|
|
||
674
Vita Coco
COCO
$3.13B
| $11.3M | 0.02% |
213,196
-38,603
|
|
||
675
Otis Worldwide
OTIS
$33.5B
| $11.3M | 0.02% |
129,351
-517,341
|
|